Optimal linker length for small molecule PROTACs that selectively target p38α and p38β for degradation

Eur J Med Chem. 2020 Sep 1:201:112451. doi: 10.1016/j.ejmech.2020.112451. Epub 2020 Jun 18.

Abstract

We report the design of hetero-bifunctional small molecules that selectively target p38α and p38β for degradation. These proteolysis targeted chimeras (PROTACs) are based on an ATP competitive inhibitor of p38α and p38β, which is linked to thalidomide analogues to recruit the Cereblon E3 ubiquitin ligase complex. Compound synthesis was facilitated by the use of a copper catalyzed "click" reaction. We show that optimization of the linker length and composition is crucial for the degradation-inducing activity of these PROTACs. We provide evidence that these chemical compounds can induce degradation of p38α and p38β but no other related kinases at nanomolar concentrations in several mammalian cell lines. Accordingly, the PROTACs inhibit stress and cytokine-induced p38α signaling. Our compounds contribute to understanding the development of PROTACs, and provide a useful tool to investigate functions of the p38 MAPK pathway and its involvement in diseases.

Keywords: Azide-alkyne click reaction; Cereblon; PROTAC linker optimization; Protein degradation; Thalidomide derivative; p38 MAPK.

MeSH terms

  • Adaptor Proteins, Signal Transducing / metabolism
  • Benzamides / chemical synthesis
  • Benzamides / pharmacology*
  • Cell Line, Tumor
  • Drug Design
  • Humans
  • Mitogen-Activated Protein Kinase 11 / antagonists & inhibitors*
  • Mitogen-Activated Protein Kinase 11 / chemistry
  • Mitogen-Activated Protein Kinase 11 / metabolism
  • Mitogen-Activated Protein Kinase 14 / antagonists & inhibitors*
  • Mitogen-Activated Protein Kinase 14 / chemistry
  • Mitogen-Activated Protein Kinase 14 / metabolism
  • Molecular Structure
  • Proteolysis / drug effects
  • Pyridones / chemical synthesis
  • Pyridones / pharmacology*
  • Structure-Activity Relationship
  • Thalidomide / analogs & derivatives*
  • Thalidomide / pharmacology*
  • Ubiquitin-Protein Ligases / metabolism
  • Ubiquitination

Substances

  • Adaptor Proteins, Signal Transducing
  • Benzamides
  • CRBN protein, human
  • PH 797804
  • Pyridones
  • Thalidomide
  • Ubiquitin-Protein Ligases
  • Mitogen-Activated Protein Kinase 11
  • Mitogen-Activated Protein Kinase 14